Eric C. Hsu, PhD

Senior Vice President, Pre-Clinical Research & Development
InMed
(NASDAQ: INM)

Dr. Hsu joined InMed with more than 18 years of scientific leadership experience in the field of gene therapy. Prior to joining InMed, he held various positions within enGene Inc., including V.P. of Research and V.P. of Scientific Affairs and Operations.